?:abstract
|
-
After 14 years as a National Institute of Diabetes and Digestive and Kidney Diseases Research Scientist in Arizona working on the etiology of obesity and type 2 diabetes mellitus among Pima Indians, he became the Director of Endocrine Research and Clinical Investigation at Eli Lilly Research Laboratories in Indianapolis before joining Pennington Biomedical in 2000 Since 2012, he has been serving as the Editor-in-Chief of Obesity in close collaboration with Dr Donna H Ryan Dr Ryan served as Co-Chair on the expert panel for the 2013 American College of Cardiology/American Heart Association/TOS evidence-based Guidelines on the Evaluation and Management of Overweight and Obesity in Adults, and she was a panel member for the 2015 Endocrine Society Systematic Evidence Review and Guidelines for Medications that Affect Body Weight
|